OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SIVC50

Air Liquide Cote d'Ivoire SA

Commodity ChemicalsVerified

Air Liquide Cote d'Ivoire SA has a fully diluted share count of 8,734,000 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's profitability and return metrics are not available in the current dataset, making it difficult to compare with industry_config preferred metrics or cohort medians. Without access to key financial ratios such as ROIC, EBITDA margins, or net profit margins, a detailed profitability analysis is not possible at this time. Segment and geographic exposure data are not disclosed in the available source documents, so it is not possible to assess revenue concentration or geographic diversification. The company's operations are likely concentrated in Cote d'Ivoire, but no specific revenue breakdown by region or business line is available for analysis. Growth trajectory data is also not available in the current dataset. No numeric deltas or revenue history are provided to assess the company's performance over time or its outlook for the current and next fiscal years. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and the lack of going-concern language in source documents. The company is reported to have low dilution risk, but no further details on potential dilution sources or adjustments are available in the valuation snapshot. Recent events, including filings or transcripts, are not disclosed in the available source documents, so no specific developments can be reported at this time.

30-day price · SIVC-140.00 (-4.7%)
Low$2600.00High$3215.00Close$2855.00As of12 May, 00:00 UTC
Profile
CompanyAir Liquide Cote d'Ivoire SA
TickerSIVC.CI
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. (unavailable from LLM output)

Classification. (unavailable from LLM output)

Air Liquide Cote d'Ivoire SA has a fully diluted share count of 8,734,000 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's profitability and return metrics are not available in the current dataset, making it difficult to compare with industry_config preferred metrics or cohort medians. Without access to key financial ratios such as ROIC, EBITDA margins, or net profit margins, a detailed profitability analysis is not possible at this time. Segment and geographic exposure data are not disclosed in the available source documents, so it is not possible to assess revenue concentration or geographic diversification. The company's operations are likely concentrated in Cote d'Ivoire, but no specific revenue breakdown by region or business line is available for analysis. Growth trajectory data is also not available in the current dataset. No numeric deltas or revenue history are provided to assess the company's performance over time or its outlook for the current and next fiscal years. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and the lack of going-concern language in source documents. The company is reported to have low dilution risk, but no further details on potential dilution sources or adjustments are available in the valuation snapshot. Recent events, including filings or transcripts, are not disclosed in the available source documents, so no specific developments can be reported at this time.
Key takeaways
  • The company has no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities.
  • Liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language in source documents.
  • Profitability and return metrics are not available, making it difficult to compare with industry benchmarks.
  • Segment and geographic exposure data are not disclosed, limiting the ability to assess revenue concentration or diversification.
  • Growth trajectory and recent events are not available in the current dataset.
  • --
  • **RATIONALES**:
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyXOF
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$6.35B-$2.13B-$2.46B-$1.30B
FY-3$7.65B$895.9M$727.4M$203.3M
FY-2$8.69B$706.2M$402.7M$449.2M
FY-1$8.51B$1.18B$895.7M$1.38B
FY0$9.28B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$15.84B$2.23B$852.0M
FY-3$15.72B$2.56B
FY-2$15.91B$2.60B$1.7M
FY-1$15.70B$3.21B$20.5M
FY0
PeriodOCFCapExFCFSBC
FY-4$1.65B-$1.30B
FY-3$1.65B-$1.62B$203.3M
FY-2$576.4M-$791.5M$449.2M
FY-1$649.3M-$448.4M$1.38B
FY0
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0$2.69B
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricSIVCActivity
Op margin5.5% medp25 -0.0% · p75 10.8%
Net margin4.1% medp25 0.1% · p75 8.8%
Gross margin20.5% medp25 12.4% · p75 29.7%
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-6.2% medp25 -13.4% · p75 -2.6%
Debt / equity37.1% medp25 10.3% · p75 82.0%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 00:03 UTC#bf08fca5
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 11:04 UTCJob: edf3e4c2